Abstract #4078

The Usefulness of Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced MRI for Follow-Up Study in Patients of Malignant Hepatic Tumors Performed RF Ablation: Correlated with Four-Phase MDCT

Jung-Hee Yoon^1,2, Eun-Joo Lee², Seong-Sook Cha², Sang-Suk Han², Suk-Jin Choi², Oh-Whan Park², Yeon-Jae Lee³, Seong-Jae Park³

¹Department of Radiology, Liver Imaging Research Group, UCSD Medical center, Hillcrest, San Diego, CA, USA; ²Department of Radiology, Busan Paik Hospital, Inje University, College of Medicine, Busan, Korea; ³Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea

Newly developed liver specific MR contrast agent, Gadoxetic acid (Gd-EOB-DTPA)! We expected that Gadoxetic acid should suggest more improved assessment of the ablative margin relative to the tumor margin in cases of RF ablation.